Software Solutions Company - Reunsurance, 1984

Patented Universal Tumor-Targeting Drug Delivery Platform Co. This pharmaceutical company has developed and patented a universal tumor-targeting drug-delivery platform that can improve the safety and efficacy of many existing chemo treatments, with the ability to target numerous different types of cancer. The technology encapsulates existing FDA-approved drugs inside lipid nanoparticles (liposomes or emulsions) coated with patented human-sourced antinuclear antibodies (ANA). The lipid nanoparticle provides long-term storage stability of the drug and controlled release of the drug over time at body-temperature, and is expected to improve the safety and efficacy profile of the drug, including passive accumulation at the tumor while not harming normal tissues. The Company's ANA, sourced from lupus patients, binds to nuclear material present in abundance in areas of necrosis (dead / ruptured cells) present in and around all solid tumors, thus anchoring the drug-filled nanoparticles at the tumor where the nanoparticle is designed to slowly release the drug directly on the tumor for more effect. As the Company's ANA is not tumor-marker specific, but rather targets necrosis present in solid tumors, the technology is designed to "universally" target many different types of cancer including breast cancer, lung, ovarian, colon, prostate, etc., as well as rare childhood cancers. The Company completed a successful proof-of-concept study at Children's Hospital using Ewing's Sarcoma transplanted in immunodeficient mice. Treatment with the Company's forumlation significantly inhibited tumor growth and extended survival times compared to control mice receiving no treatment or treatment with plain liposomal doxorubicin. The Company has been granted Orphan Drug Designation by the FDA on 2 of the lead drug formulations, providing FDA fee waivers, priority review, and 7-years exclusivity upon market approval. The orphan pathway also enables the potential for New Drug Approval after successful completion of Phase 2 studies, with Phase III data collected while in the market, thus significantly lowering the time and cost to market approval. This same drug inside the Company's tumor targeting delivery system will likely have potential to treat other pediatric cancers, and/or cancers in larger adult populations. As the Company's platform and ANA has the potential to improve the safety and efficacy of many existing FDA approved drugs or even compounds in development, the Company anticipates the potential for multiple licensing agreements with multiple pharmaceutical companies seeking to improve their existing portfolio and extend patient life as they advance into clinical stage. And as it may be possible to file for New Drug Approval following successful Phase II studies, the Company anticipates licensing potential at early clinical stage. Multiple exit opportunities exist with high impact & high ROI. The Company is seeking a supportive capital partner to maintain momentum up to $20M. Funding will be used to advance the lead drug through formal Investigational New Drug enabling studies towards New Drug Approval; estimating $3-5 Million now to advance into clinical studies. Preclinical / animal studies estimate ($3 - 5 Million and 12-18 months); follwed by potential combined Phase I-II clinical study in a rare cancer (approximately 2-3 years and $10M) to potential New Drug Approval, plus additional capital to advance additional drugs in the pipeline simultaneously, thus adding tremendous value to the Company's valuation. Valuations of pharma companies often exceed $100 Million valuation at Phase I (approx. 18 months), and New Drug Approval can exceed valuations above $1 Billion. The Company has numerous, improved high-impact cancer drugs advancing with proper support. NDA is required for comprehensive Confidential Information Memorandum crafted by ProNova Partners. Detailed Information Competition: Trying to improve existing therapies and develop novel approaches to hard to treat cancers. Growth & Expansion: Huge market potential. Financing: If the price and deal structure is right. Support & Training: Transition team included. Reason for Selling: Seeking supportive capital partners to take to the next level(s). .

Our client is offering a next generation, patented medical device for the treatment of internal hemorrhoids. The procedure is painless, non-invasive, requires no anesthesia, is conducted in under 2 minutes, and can be performed in any medical setting: a doctor's office, a surgery center, an endo suite, or a hospital. Our client's product is a small, disposable, medical device that eliminates hemorrhoids. A physician uses this device by deploying a tiny rubber band on the base of the hemorrhoid. This procedure is known as rubber band ligation, and it is the #1 recommended treatment for internal hemorrhoids by the American College of Gastroenterology. Patients no longer need to use ineffective creams or receive painful, invasive surgery. Our client's device offers a permanent solution for their hemorrhoids. The device is currently manufactured in the USA through an FDA approved, ISO 13485 contract manufacturer, who specializes in medical devices. The device is sold directly to physicians of different specialties, including gastroenterologists, colorectal surgeons, GYNs, urologists and primary care physicians. The biggest targeted audience are gastroenterologists. NDA is required to secure comprehensive Confidential Information Memorandum. Growth and epansion: Nearly half of adults over the age of 50 will develop symptomatic hemorrhoids. In the U.S. alone, an estimated 60,000,000 people have experienced hemorrhoid symptom(s) at some point in their lives. Annually, over 20,000,000 people in the U.S. use an over-the-counter hemorrhoid treatment and 75% report a reoccurrence. These patients no longer need to use ineffective creams or receive painful, invasive surgery. Our client's device offers a permanent solution for their hemorrhoids. Financing is if the price and deal structure is right, and support and training is provided as required. Facilities are Outlined in CIM. Reason for selling is that the owners wish to move on to other projects.

This profitable Company is a unique California medical network that can be customized to the needs of each individual client. The Company has years of experience in PPO. The business model generates recurring revenue and the technology allows the subscribing clients to customize the network to fit their own needs. The Company also offers several re-pricing options to payers. The Company reviews provider performance to assure compliance with the network's evidence-based treatment guidelines, improving outcomes and offers metrics germane to the medical treatment within the network, allowing payers to monitor performance. The Company is a resource for Group Medical Insurance Providers and Payers, and for Workers Comp Payers to create a custom network of highly qualified medical providers, specific to California. The Company's network and technology allow Payers and Employers to tailor their network to their own specific needs. The payers subscribe to the Company's network generating recurring revenue for the Company. NOTE: This is a re-listing of a major purchase opportunity for a rapidly expanding, profitable California medical network. The initial response to the original listing of this opportunity was huge. A large investment group signed a Letter of Intent To Purchase early on, thus removing the opportunity from the marketplace. The holder of the LOI, following numerous delays over many months, was unable to proceed due to unexpected internal problems separate from their signing the LOI or their completed due diligence. Therefore, this terrific opportunity is now again available for purchase. Our Client's business and profits continue to expand. They have re-listed this purchase opportunity at $3M (USD). This sale price, based on current revenues, growth and profits, should be recovered by a Buyer in short order. Please do not respond to this opportunity unless you will provide proof of funds prior to any demos or negotiations; i.e. the capability to make an acquisition of $3M dollar (USD). The Seller only wishes to work with interested Buyers who, once they are satisfied with their due diligence, are prepared to proceed immediately. We do ask for your understanding in these regards as our initial listing generated a very high volume of responses. NDA is required to secure first round of comprehensive Confidential Information Memorandum (CIM) crafted by ProNova Partners. Facilities: Current rent is $1975 per month for the 1050 sq ft space. Many staff currently work from home, and some have remained in the office space in Tracy, California. Current lease extends through January 31, 2021, so the Buyer may choose to keep this office space or move the Business. The current space allows for social distancing and COVID compliance for those staff who continue to work in the office and not from home. Competition: This Company is unique in the industry and competes against large national players. The Company beats the competition by providing a higher level of customer service, customization of medical provider networks, and competes on price. Growth & Expansion: The Sellers have grown the business to its current level with a slim 'guerilla' marketing budget. An ideal Buyer would have a budget for marketing and advertising, as well as for staffing to handle more leads. With the right Buyer, this Company is primed to grow! Support & Training: As needed. Financing: Available with the right offer Reason for Selling: Retirement.

This is in the presentation of a well-established high-performance gear and bag company for First Responders - Fire, Police, and EMS professionals. The strongly established foundation that is being sold due to changes and personal circumstances has strong profit margins with a steady and repeatable process for income including an opportunity for growth; very little marketing spending and strong word of mouth and organic growth. Key Investment Considerations: * There is No other Company that is offering a similar service essentially in a league all of their own * Nearly all income is from repeat business where they have been able to sustain and grow only through word-of-mouth marketing * Owner is a former Fireman who knows, understands, and has built to spec the items for professionals within Police, Fire, and EMTs which can withstand heavy wear and tear * By using subcontractors so that products are built to spec and offer the highest quality to the professionals in these spaces * Once a client is turned on to these products, they are in essence a client for life * The Company uses only top-tier materials and a proprietary process for assembly ensuring a lifetime warranty on all products * High-quality workmanship and products that are built to last * With their established marketplace and strong clientele what is needed at this point in time is a directed marketing effort With proper marketing and pursuant to bidding on available contracts there are massive growth opportunities available to a new owner considering reputation and company processes. NDA is required to secure a comprehensive Confidential Information Memorandum (CIM) crafted by ProNova Partners. Facilities: Not available, would need new Company location. Competition: Yes, however processes have been able to in a number of ways keep the Company ahead of the competition. Growth & Expansion: Abundant growth opportunities; little to no marketing up to this point, the flip of a switch, and the company can experience significant growth in the years to come. Financing: Depending on offer and structure may be acceptable. Support & Training: As needed. Reason for Selling: Personal Reasons - Retirement

With a previous background in insurance, the Seller opened this independent agency in 2014 and built it from the ground up. By emphasizing personalized service and trust, there are now 770 policies in force. Eighty-two percent are Medicare Advantage policies, while the other 18 percent are composed of prescription plans, Medicare supplement plans, and dental plans. Only 2 percent are healthcare plans for those under 65. Strategic investments in advertising through radio, TV, and social media have significantly boosted brand recognition, fueling an impressive 65% growth trajectory since 2021. Buyer Qualifications: Potential Buyers must have a direct appointment with Wellcare to be considered. NDA is required to secure the comprehensive Confidential Information Memorandum (CIM) crafted by ProNova Partners.

As technology has become and will continue to become a driving factor within economies worldwide, the marketplace for Value Added Resellers (VARs) is growing at an astounding rate with an expected CAGR of 10% Year-over-Year through the year 2028. What makes VARs necessary within the business landscape - most large and medium-sized Companies do not order enough volume for purchasing direct from a manufacturer and can benefit from purchasing from a go-between such as a VAR, thereby creating a strong need for participants within the marketplace who function as a go-between within a B2B environment. For a VAR to maintain a livelihood and grow within this highly competitive marketplace, Resellers must have access to attractively priced goods from manufacturers, resellers, and wholesalers, and the necessary technologies to help streamline business and ensure that pricing opportunities are not overlooked (on the part of the VAR and their customer). The firms which can capture most and/or all sales within the Reseller industry will be the firms who will prevail in the years to come, ideally those who have the capability for: -Displaying a high capacity for tech solutions and customizations -An abundance of data analysis and KPIs -Sales and marketing -Quoting and sourcing -and overall Integrations and customizations Since opening its doors nearly 20 years ago this Company has created a software solution for quoting, procurement, discounting, a vast array of KPIs, and a content library that in sum is yet to be rivaled by other firms in the space. By creating the necessary relations with only the most optimal suppliers for maintaining a reputation of quality while maintaining an outstanding profit margin, it is these factors while developing strategies and sales channels that the Company has been able to boast $3MM-$4MM in gross sales in its pre-covid year. With their most recent integrations (within the last 1-2 years) the Company is NOW able to harness the expected growth within the reseller space and is expecting a massive adoption of this technology among the resellers who are aware of the demand and the impact of tech integration with these capabilities Key Investment Considerations: o Over $10M investment into the platform development, o 5000+ Tech resellers serviced, o $32B of transactions in the last 3 Years, o Presence in the US, CA, IN, SL o Full-fledged India Center with Development, QA, Marketing, and Sales team o Development team in Sri Lanka o 55%+ profitability over the last 3 years o Cloud native SaaS platform o Turnkey system and solid foundation for growth o Robust growth potential and strategies that have been clearly defined and identified by the Seller o Strong customer and referral base years of premium service offering leading reputation for quality products and pricing o 20+ years in the making o Strong process for instilling R&D and maintaining an elevated level of Quality Control o Robust and unique one-of-a-kind content library The Company and brand are very well established and only need a directed effort related to marketing and the Company can far exceed past sales levels. With proper marketing and underbidding on available contracts there are massive growth opportunities available to a new Owner. NDA is required to secure a comprehensive Confidential Information Memorandum (CIM).

Our client sources an excellent quality bourbon that has a higher yield than a traditional 6-8-year aged bourbon. Due to the higher yield because of less evaporation, they are able to keep the MSRP very competitive and are growing rapidly. They partner with a smaller craft distillery as their co-packer in order to keep production costs down. The founder is a rising, Tennessee-based singer/songwriter with thousands of followers. He uses, and will continue to use, his social media and concerts to publicize the bourbon and allows fans to become partial minority owners of the brand, thus far garnering approximately $200,000 as of the beginning of December 2022. Since the launch of the bourbon brand in 2018 it has earned some of the largest and most prestigious awards which can be awarded in the spirit industry. 1) Named Top 6 in the World in Forbes 2) Featured in Billboard, Rolling Stone, Uproxx, American Songwriter 3) Platinum Los Angeles 4) Double Gold San Francisco (largest award in the world for whiskey to earn) 5) Double Gold New York International 6) Double Gold New York Best Fifty 7) Gold Las Vegas 8) Silver Denver Our client has created a supportive community of real fans who love both the founder's music and the bourbon. Our client has taken the brand as far as 26 states. They will soon expand into Canada and exporting to South Africa & Vietnam is on the horizon. The founder and his partner are willing to stay on the team to bring the Bourbon brand to a much higher national level with a well-capitalized strategic buyer or owner-operator who is passionate about the bourbon industry. An NDA is required to secure a comprehensive Confidential Information Memorandum (CIM). Growth & Expansion: In CIM - NDA Required. Financing: If the price and deal structure is right Support & Training: Provided at no charge to enable a smooth transition Reason for Selling: Other Projects

Confidential Information Memorandum (CIM) available upon receipt of our short online NDA. * It is estimated that the marketplace for connected cars and automobile data is will reach $400BN by 2030. * There are currently ~280MM registered automobiles in the US today with ~65MM of them being connected cars * The Company has created a process that while working with 3rd party Companies in the space and simultaneously creating a near proprietary technology is able to harness processes related to car data, thereby creating an opportunity for Companies looking to enter the aftermarket space for consumers and/or enterprises already in the automobile space, * Ideally this would be an add-on solution for any Company that is in the fleet-auto space, or looking to create an expansive and/or sweeping platform for the Consumer space NDA is required to secure comprehensive Confidential Information Memorandum (CIM). Detailed Information: Facilities: Home Based Competition: Few if any Growth & Expansion: Ample Financing: Depending on offer and structure may be acceptable minimal if any Support & Training: As needed. Reason for Selling: Existing opportunities